Initial Weight Management Consultation

Initial Weight Management Consultation Weight history including diet, exercise, lifestyle and medical causes of weight gain: - Patient accompanied by spouse, Mr. John Smith. - Patient reports a steady weight gain of approximately 10 kg over the past two years, despite attempts at dieting. - Previous weight-management strategies included several commercial diet programmes (e.g., Weight Watchers, Keto diet) and increased home-based exercise, none of which resulted in sustained weight loss. Patient also tried intermittent fasting for 3 months last year with minimal success. - Patient denies smoking. Occasional social alcohol consumption, 2-3 units per week. - Patient attributes some weight gain to stress-eating due to work pressures and reduced physical activity following a knee injury 18 months ago. Past medical history: - Hypertension (diagnosed 5 years ago, well-controlled with medication). - Osteoarthritis of the left knee (diagnosed 2 years ago). - Previous surgeries: Appendicectomy (1998). - Weight-related comorbidities: Pre-diabetes (HbA1c 6.2% on recent blood test), dyslipidaemia (elevated LDL-C). Relevant Blood Tests: - 25/10/2024: HbA1c 6.2% (elevated), Total Cholesterol 5.8 mmol/L (elevated), LDL-C 3.5 mmol/L (elevated), HDL-C 1.1 mmol/L (low), Triglycerides 2.1 mmol/L (elevated), TSH 2.1 mIU/L (normal), Fasting Glucose 6.8 mmol/L (elevated), Liver Function Tests within normal limits, Renal Function Tests within normal limits. Patient Goals & Expectations: - Patient's primary goal is to lose 15-20 kg to improve knee pain and reduce cardiovascular risk. Expresses a desire to feel more energetic and improve overall health. Expectations include a structured plan and ongoing support. Weight, Height and BMI: - Weight: 105 kg, Height: 1.70 m, BMI: 36.3 kg/m². Body Composition Analysis: - Body fat percentage: 42% - Muscle mass percentage: 28% - Visceral fat: 15 Blood Pressure: - Blood pressure: 145/92 mmHg (sitting, right arm). - Other examination findings: Abdominal obesity, mild oedema in both ankles, clear chest, normal heart sounds, knee examination reveals mild effusion and crepitus in the left knee. Obesity Class: - Stage of obesity: Class II Obesity. Impression: - Clinician’s impression: Patient is a 55-year-old male with Class II obesity, hypertension, pre-diabetes, and dyslipidaemia, all of which are exacerbated by his current weight. Significant lifestyle contributors and a clear desire for intervention are noted. Patient is motivated and has made previous attempts at weight management. - Whether weight-loss medication may help: Weight-loss medication is likely to be beneficial in conjunction with comprehensive lifestyle modifications, given the patient's BMI and weight-related comorbidities. Medication Counselling: - Advice provided regarding weight-loss medication: Discussed options including GLP-1 receptor agonists (e.g., semaglutide). Explained mechanism of action, potential benefits (weight loss, glycaemic control, cardiovascular benefits), common side effects (nausea, constipation), and administration via subcutaneous injection. Emphasised that medication is an adjunct to diet and exercise. Plan and Rationale: - Medication agreed upon by patient and clinician, including consent status: Patient has given verbal consent to start Semaglutide (Ozempic) 0.25mg weekly, with titration as advised. Patient understands the commitment required for long-term management. - Follow-up timeframe: Review in 4 weeks to assess tolerance, efficacy, and titrate medication if appropriate. - Lifestyle advice given: Referral to a dietitian for structured meal planning and education on healthy eating. Recommended a gradual increase in low-impact exercise (e.g., swimming, cycling) focusing on activities that minimise stress on the knee. Encouraged daily step count goal setting. - Referrals made: Referral to a physiotherapist for a tailored exercise programme for knee osteoarthritis. Referral to a community weight management programme for additional support. - Medication administration details including site: Patient instructed on self-administration of Semaglutide via subcutaneous injection into the abdomen, thigh, or upper arm, rotating injection sites. Has consent been obtained to communicate with NHS GP? - Consent status for communication with NHS GP: Yes, verbal consent obtained. NHS letter created and admin team tasked to send direct to GP? - NHS letter creation and tasking status: Yes, letter created and admin team tasked for direct dispatch to GP on 1 November 2024. Patient information letter created and shared with patient? - Patient information letter creation and sharing status: Yes, patient information leaflet on Semaglutide and lifestyle changes created and shared with patient on 1 November 2024.